These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26881032)

  • 1. Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Delbarba A; Abate G; Prandelli C; Marziano M; Buizza L; Arce Varas N; Novelli A; Cuetos F; Martinez C; Lanni C; Memo M; Uberti D
    Oxid Med Cell Longev; 2016; 2016():5923938. PubMed ID: 26881032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs.
    Gatta L; Cardinale A; Wannenes F; Consoli C; Armani A; Molinari F; Mammi C; Stocchi F; Torti M; Rosano GM; Fini M
    Neurosci Lett; 2009 Mar; 453(1):36-40. PubMed ID: 19429011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodromal metabolic phenotype in MCI cybrids: implications for Alzheimer's disease.
    Silva DF; Santana I; Esteves AR; Baldeiras I; Arduino DM; Oliveira CR; Cardoso SM
    Curr Alzheimer Res; 2013 Feb; 10(2):180-90. PubMed ID: 22746213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
    J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.
    Lunnon K; Ibrahim Z; Proitsi P; Lourdusamy A; Newhouse S; Sattlecker M; Furney S; Saleem M; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Coppola G; Geschwind D; Simmons A; Lovestone S; Dobson R; Hodges A;
    J Alzheimers Dis; 2012; 30(3):685-710. PubMed ID: 22466004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
    Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
    Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients.
    Arce-Varas N; Abate G; Prandelli C; Martínez C; Cuetos F; Menéndez M; Marziano M; Cabrera-García D; Fernández-Sánchez MT; Novelli A; Memo M; Uberti D
    Curr Alzheimer Res; 2017; 14(1):112-122. PubMed ID: 27748187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Zhao S; Zhao J; Zhang T; Guo C
    Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease.
    Mota SI; Costa RO; Ferreira IL; Santana I; Caldeira GL; Padovano C; Fonseca AC; Baldeiras I; Cunha C; Letra L; Oliveira CR; Pereira CM; Rego AC
    Biochim Biophys Acta; 2015 Jul; 1852(7):1428-41. PubMed ID: 25857617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease.
    Mahapatra G; Gao Z; Bateman JR; Lockhart SN; Bergstrom J; DeWitt AR; Piloso JE; Kramer PA; Gonzalez-Armenta JL; Amick KA; Casanova R; Craft S; Molina AJA
    Alzheimers Dement; 2023 Apr; 19(4):1466-1478. PubMed ID: 35870133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of interleukin-18 receptor in blood cells of subjects with mild cognitive impairment and Alzheimer's disease.
    Salani F; Ciaramella A; Bizzoni F; Assogna F; Caltagirone C; Spalletta G; Bossù P
    Cytokine; 2013 Feb; 61(2):360-3. PubMed ID: 23201485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective mitochondrial respiration, altered dNTP pools and reduced AP endonuclease 1 activity in peripheral blood mononuclear cells of Alzheimer's disease patients.
    Maynard S; Hejl AM; Dinh TS; Keijzers G; Hansen ÅM; Desler C; Moreno-Villanueva M; Bürkle A; Rasmussen LJ; Waldemar G; Bohr VA
    Aging (Albany NY); 2015 Oct; 7(10):793-815. PubMed ID: 26539816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
    Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
    J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Folate Metabolites and Mitochondrial Function in Peripheral Blood Cells in Alzheimer's Disease: A Matched Case-Control Study.
    Lv X; Zhou D; Ge B; Chen H; Du Y; Liu S; Ji Y; Sun C; Wang G; Gao Y; Li W; Huang G
    J Alzheimers Dis; 2019; 70(4):1133-1142. PubMed ID: 31306134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Lysosomal Enzymes Expression Levels in Peripheral Blood of Mild- and Severe-Alzheimer's Disease and MCI Patients: Implications for Regenerative Medicine Approaches.
    Morena F; Argentati C; Trotta R; Crispoltoni L; Stabile A; Pistilli A; di Baldassarre A; Calafiore R; Montanucci P; Basta G; Pedrinolla A; Smania N; Venturelli M; Schena F; Naro F; Emiliani C; Rende M; Martino S
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in Immune Responses Are Associated with Dysfunctional Intracellular Signaling in Peripheral Blood Mononuclear Cells of Men and Women with Mild Cognitive Impairment and Alzheimer's disease.
    Vasantharekha R; Priyanka HP; Nair RS; Hima L; Pratap UP; Srinivasan AV; ThyagaRajan S
    Mol Neurobiol; 2024 May; 61(5):2964-2977. PubMed ID: 37957423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
    Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
    J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Rai N; Kumar R; Desai GR; Venugopalan G; Shekhar S; Chatterjee P; Tripathi M; Upadhyay AD; Dwivedi S; Dey AB; Dey S
    J Alzheimers Dis; 2016 Oct; 54(3):1147-1155. PubMed ID: 27567861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial depletion in CD4
    Terzioğlu G; Örmeci B; Türksoy Ö; Sayman C; Çınar N; Öztürk GA; Demirel GY
    Mech Ageing Dev; 2017 Oct; 167():24-29. PubMed ID: 28923392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.